Arsenic enhances matrix metalloproteinase-14 expression in fibroblasts

J Toxicol Environ Health A. 2008;71(16):1053-5. doi: 10.1080/15287390802114998.

Abstract

This study focused on the effects of arsenic (As) on fibroblast-derived matrix metalloproteinase (MMP)-2 and -14 levels, as these proteins were reported to be associated with tumor progression. Arsenic was found to promote production of the fibroblast-derived active form of MMP-2. Further, As at 100 or 1000 microM increased MMP-14 expression levels in fibroblasts. In addition, 1000 microM mercury (Hg) but not As increased pro-MMP-2 protein, which is involved in the conversion of the proenzyme into its active form. Since MMP-14 is an activator of pro-MMP-2, data suggest that As promotes production of fibroblast-derived active form of MMP-2 through increased expression of MMP-14. Evidence indicates that As appeared to be less effective than Hg in the conversion of pro-MMP-2 into its active form.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arsenic / pharmacology*
  • Cells, Cultured
  • Enzyme Activation / drug effects
  • Fibroblasts / enzymology
  • Fibroblasts / metabolism*
  • Matrix Metalloproteinase 14 / drug effects*
  • Matrix Metalloproteinase 14 / metabolism
  • Matrix Metalloproteinase 2 / drug effects*
  • Matrix Metalloproteinase 2 / metabolism

Substances

  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 14
  • Arsenic